Claris Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Buy
1,023
+3
+0.3% +$986 0.16% 129
2025
Q4
$358K Sell
1,020
-1
-0.1% -$338 0.19% 114
2025
Q3
$330K Buy
+1,021
New +$318K 0.19% 111
2025
Q2
Sell
-1,043
Closed -$385K 140
2025
Q1
$385K Hold
1,043
0.25% 92
2024
Q4
$385K Buy
+1,043
New +$436K 0.25% 92

Other funds holding ELV

Claris Financial's ELV Position: Q1 2026 in Review

Claris Financial increased its Elevance Health (ELV) stake by 0.29% in Q1 2026, buying an estimated $986 and bringing the position to 1,023 shares worth $300K. The position accounts for 0.16% of the portfolio, ranked #129.

Claris Financial first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. The position peaked at $385K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Claris Financial held 1,023 shares of Elevance Health worth $300K as of Q1 2026.
  • Claris Financial bought 3 Elevance Health shares in Q1 2026, an estimated $986.
  • Elevance Health made up 0.16% of Claris Financial's portfolio in Q1 2026, its #129 holding.
  • Claris Financial first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
  • Claris Financial's Elevance Health position peaked at $385K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Claris Financial's 13F filing for Q1 2026, filed 18 May 2026.